ASCORBIC ACID

ASCORBIC ACID was reported 23372 times

ASCORBIC ACID is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPENDICOLITH 117 0.3023
1 SLEEP DISORDER THERAPY 46 0.2323
2 ANTACID THERAPY 30 0.2308
3 GRIP STRENGTH 51 0.2227
4 PRESBYACUSIS 51 0.1656
5 ANALGESIC THERAPY 49 0.1526
6 DRUG THERAPY 46 0.1357
7 DEEP VEIN THROMBOSIS POSTOPERATIVE 246 0.1228
8 SWOLLEN JOINT COUNT 30 0.1200
9 CONGENITAL HIATUS HERNIA 26 0.1140
10 LUPUS VULGARIS 136 0.1079
11 ANTICOAGULANT THERAPY 30 0.1056
12 BACTEROIDES INFECTION 26 0.0996
13 C-REACTIVE PROTEIN 90 0.0971
14 FACET JOINT SYNDROME 281 0.0862
15 X-RAY ABNORMAL 154 0.0860
16 VAGINAL FLATULENCE 26 0.0858
17 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 54 0.0808
18 SWOLLEN JOINT COUNT INCREASED 256 0.0802
19 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 44 0.0784
20 PLEURAL THICKENING 52 0.0760
21 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 157 0.0757
22 RHEUMATIC FEVER 337 0.0755
23 DISLOCATION OF VERTEBRA 140 0.0613
24 DUODENAL ULCER PERFORATION 452 0.0607
25 PLEURAL FIBROSIS 60 0.0589
26 BLOOD MAGNESIUM INCREASED 53 0.0588
27 INTRAMEDULLARY ROD INSERTION 120 0.0585
28 SENSITISATION 44 0.0580
29 CRYSTAL NEPHROPATHY 34 0.0574
30 EJECTION FRACTION 32 0.0551
31 RETINITIS 95 0.0549
32 PERIPHERAL VENOUS DISEASE 219 0.0536
33 RHEUMATOID FACTOR POSITIVE 290 0.0502
34 C-REACTIVE PROTEIN ABNORMAL 315 0.0491
35 TEMPERATURE REGULATION DISORDER 108 0.0484
36 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 342 0.0477
37 MUSCLE INJURY 388 0.0468
38 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 290 0.0446
39 FOLLICULITIS 465 0.0443
40 OPEN REDUCTION OF FRACTURE 50 0.0436
41 PORPHYRIA ACUTE 59 0.0411
42 HELICOBACTER INFECTION 406 0.0395
43 ANAEMIA POSTOPERATIVE 51 0.0391
44 BONE CYST 35 0.0373
45 PEMPHIGUS 433 0.0346
46 BURSITIS 415 0.0342
47 FRACTURE NONUNION 46 0.0336
48 HAND DEFORMITY 423 0.0322
49 BONE EROSION 113 0.0319
50 VERTEBRAL FORAMINAL STENOSIS 25 0.0303
51 HYPERCHOLESTEROLAEMIA 293 0.0303
52 HYPERPHOSPHATAEMIA 64 0.0297
53 POLYCYSTIC OVARIES 46 0.0296
54 BLOOD PHOSPHORUS INCREASED 81 0.0296
55 DEAFNESS TRANSITORY 25 0.0293
56 BREAST CANCER STAGE III 189 0.0292
57 LOW TURNOVER OSTEOPATHY 111 0.0278
58 LIP DRY 248 0.0273
59 AUTOIMMUNE DISORDER 256 0.0262
60 PERICARDITIS 429 0.0255
61 SYNOVITIS 458 0.0254
62 SPONDYLOLISTHESIS 42 0.0242
63 LUMBAR RADICULOPATHY 28 0.0242
64 BILIARY DYSKINESIA 41 0.0241
65 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 55 0.0239
66 MUSCLE SPASTICITY 286 0.0233
67 GRIP STRENGTH DECREASED 204 0.0232
68 JOINT RANGE OF MOTION DECREASED 305 0.0227
69 SERONEGATIVE ARTHRITIS 26 0.0227
70 IRRITABLE BOWEL SYNDROME 469 0.0219
71 OSTEOSCLEROSIS 34 0.0216
72 CHOLECYSTITIS CHRONIC 144 0.0215
73 GLOSSODYNIA 472 0.0211
74 COLONIC POLYP 34 0.0206
75 FIBROMYALGIA 497 0.0204
76 WOUND INFECTION 219 0.0200
77 DRUG TOLERANCE DECREASED 56 0.0199
78 OBSTRUCTIVE SLEEP APNOEA SYNDROME 29 0.0199
79 TOTAL LUNG CAPACITY DECREASED 31 0.0194
80 EXOSTOSIS 173 0.0189
81 BLEPHAROSPASM 119 0.0189
82 DEAFNESS NEUROSENSORY 61 0.0185
83 ONYCHOMADESIS 77 0.0183
84 CONTRAINDICATED PRODUCT ADMINISTERED 545 0.0180
85 COELIAC DISEASE 176 0.0179
86 EPIGASTRIC DISCOMFORT 70 0.0179
87 MATERNAL EXPOSURE TIMING UNSPECIFIED 67 0.0178
88 IMPAIRED HEALING 580 0.0176
89 LIVE BIRTH 147 0.0176
90 RHINITIS ALLERGIC 78 0.0175
91 EAR PAIN 338 0.0174
92 FOOD ALLERGY 132 0.0171
93 WALKING AID USER 112 0.0170
94 FEMALE GENITAL TRACT FISTULA 29 0.0170
95 ESSENTIAL HYPERTENSION 31 0.0169
96 MITRAL VALVE PROLAPSE 28 0.0168
97 WOUND 468 0.0167
98 RADICULOPATHY 44 0.0167
99 AORTIC STENOSIS 58 0.0166
100 ONYCHOMYCOSIS 73 0.0166
101 SEBORRHOEIC KERATOSIS 24 0.0165
102 SEDATION COMPLICATION 42 0.0164
103 NIGHT SWEATS 512 0.0159
104 LIVER INJURY 388 0.0158
105 SCIATICA 243 0.0152
106 OBESITY 242 0.0152
107 MEDICAL DEVICE REMOVAL 26 0.0150
108 HYPERLIPIDAEMIA 175 0.0146
109 LOWER RESPIRATORY TRACT INFECTION 665 0.0146
110 SPINAL OSTEOARTHRITIS 126 0.0143
111 BLOOD URIC ACID INCREASED 82 0.0142
112 BODY TEMPERATURE INCREASED 289 0.0142
113 KYPHOSIS 25 0.0141
114 OSTEOARTHRITIS 593 0.0140
115 SYSTEMIC LUPUS ERYTHEMATOSUS 488 0.0137
116 NEUROGENIC BLADDER 29 0.0137
117 IRON DEFICIENCY 61 0.0135
118 VENTRICULAR FIBRILLATION 149 0.0134
119 PRESCRIBED OVERDOSE 258 0.0133
120 FOETAL DEATH 69 0.0133
121 APPENDICITIS 124 0.0133
122 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 67 0.0132
123 HYPOPHOSPHATAEMIA 97 0.0131
124 LUMBAR SPINAL STENOSIS 38 0.0130
125 LOWER LIMB FRACTURE 248 0.0129
126 PUSTULAR PSORIASIS 44 0.0128
127 PULMONARY FIBROSIS 239 0.0124
128 TYPE 2 DIABETES MELLITUS 419 0.0124
129 HIP ARTHROPLASTY 189 0.0123
130 NAIL DISORDER 106 0.0121
131 BLOOD CHOLESTEROL INCREASED 563 0.0121
132 CREATININE RENAL CLEARANCE DECREASED 48 0.0120
133 EXCORIATION 30 0.0118
134 PROCTITIS 33 0.0118
135 MYASTHENIA GRAVIS 94 0.0116
136 ARTHROPATHY 646 0.0116
137 RESPIRATORY DISORDER 339 0.0113
138 FEMUR FRACTURE 349 0.0113
139 PSORIATIC ARTHROPATHY 455 0.0112
140 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 192 0.0112
141 CHRONIC SINUSITIS 42 0.0112
142 CARDIOGENIC SHOCK 157 0.0109
143 FINGER DEFORMITY 53 0.0109
144 SPONDYLITIS 39 0.0107
145 BREAST CANCER STAGE II 89 0.0107
146 LUPUS-LIKE SYNDROME 97 0.0107
147 DIVERTICULUM 76 0.0107
148 HAEMORRHAGIC ANAEMIA 47 0.0107
149 LUNG OPACITY 28 0.0106
150 OSTEOPENIA 161 0.0106
151 PULMONARY INFARCTION 25 0.0106
152 RASH VESICULAR 51 0.0105
153 EYE INJURY 32 0.0105
154 PLEURITIC PAIN 29 0.0105
155 ULCER HAEMORRHAGE 70 0.0103
156 RED BLOOD CELL SEDIMENTATION RATE INCREASED 114 0.0103
157 CANDIDIASIS 41 0.0102
158 RETROPERITONEAL HAEMORRHAGE 25 0.0101
159 AORTIC ARTERIOSCLEROSIS 26 0.0101
160 TROPONIN INCREASED 76 0.0100
161 IMMUNODEFICIENCY 148 0.0099
162 FOOT DEFORMITY 110 0.0099
163 KNEE ARTHROPLASTY 208 0.0099
164 FUNCTIONAL GASTROINTESTINAL DISORDER 34 0.0098
165 INFUSION SITE REACTION 29 0.0097
166 GAIT INABILITY 318 0.0095
167 ENDODONTIC PROCEDURE 24 0.0095
168 STRESS FRACTURE 51 0.0094
169 HEPATIC ENZYME INCREASED 633 0.0093
170 JOINT DISLOCATION 97 0.0092
171 RESPIRATORY SYMPTOM 26 0.0091
172 PNEUMONIA ASPIRATION 228 0.0091
173 FIBULA FRACTURE 26 0.0090
174 INFUSION RELATED REACTION 597 0.0090
175 NORMOCHROMIC NORMOCYTIC ANAEMIA 27 0.0090
176 VITAMIN D DEFICIENCY 87 0.0089
177 SHOULDER ARTHROPLASTY 24 0.0089
178 SPINAL FUSION SURGERY 36 0.0089
179 BLISTER 496 0.0088
180 IRON DEFICIENCY ANAEMIA 81 0.0088
181 RENAL FAILURE CHRONIC 67 0.0087
182 BILIARY COLIC 25 0.0086
183 PRODUCT LABEL CONFUSION 50 0.0086
184 RENAL CYST 68 0.0086
185 BENIGN PROSTATIC HYPERPLASIA 44 0.0085
186 BUNDLE BRANCH BLOCK LEFT 36 0.0085
187 SLEEP APNOEA SYNDROME 162 0.0085
188 HAEMATOCRIT DECREASED 168 0.0085
189 MYOSITIS 76 0.0085
190 BACK INJURY 92 0.0085
191 SYNOVIAL CYST 39 0.0084
192 INJURY 593 0.0084
193 CARPAL TUNNEL SYNDROME 118 0.0084
194 STOMATITIS 511 0.0084
195 SCOLIOSIS 52 0.0084
196 INTERVERTEBRAL DISC DEGENERATION 77 0.0083
197 JOINT SWELLING 1000 0.0083
198 DYSLIPIDAEMIA 42 0.0083
199 SPINAL COLUMN STENOSIS 39 0.0082
200 MITRAL VALVE INCOMPETENCE 93 0.0082
201 REGURGITATION 28 0.0081
202 DIFFICULTY IN WALKING 28 0.0081
203 BLOOD CALCIUM DECREASED 91 0.0081
204 TRICUSPID VALVE INCOMPETENCE 64 0.0080
205 MUSCULOSKELETAL PAIN 420 0.0080
206 PRE-EXISTING CONDITION IMPROVED 50 0.0080
207 HEPATIC CIRRHOSIS 149 0.0079
208 AORTIC VALVE INCOMPETENCE 33 0.0077
209 THERAPEUTIC PRODUCT EFFECT DECREASED 347 0.0077
210 CAROTID ARTERY STENOSIS 27 0.0077
211 OSTEOPOROSIS 318 0.0077
212 GASTROOESOPHAGEAL REFLUX DISEASE 621 0.0077
213 SINUSITIS 790 0.0077
214 BUNDLE BRANCH BLOCK RIGHT 35 0.0076
215 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 128 0.0075
216 ORTHOPNOEA 24 0.0075
217 ESCHERICHIA URINARY TRACT INFECTION 32 0.0075
218 FULL BLOOD COUNT ABNORMAL 79 0.0075
219 BLOOD CALCIUM INCREASED 65 0.0074
220 VITAMIN B12 DEFICIENCY 30 0.0074
221 WHEEZING 438 0.0074
222 HYPOVOLAEMIA 43 0.0073
223 ATELECTASIS 71 0.0073
224 BLOOD TEST ABNORMAL 103 0.0073
225 BLOOD ALBUMIN DECREASED 58 0.0073
226 DRY MOUTH 593 0.0073
227 MULTIPLE MYELOMA 34 0.0073
228 GALLBLADDER DISORDER 130 0.0073
229 LEFT VENTRICULAR HYPERTROPHY 31 0.0072
230 DELIRIUM 251 0.0072
231 RHEUMATOID ARTHRITIS 817 0.0072
232 DISABILITY 142 0.0072
233 ROAD TRAFFIC ACCIDENT 300 0.0072
234 HYSTERECTOMY 61 0.0070
235 URINE ABNORMALITY 32 0.0070
236 LUNG NEOPLASM 30 0.0070
237 APPENDICECTOMY 25 0.0070
238 ECCHYMOSIS 48 0.0070
239 OEDEMA 378 0.0070
240 THROAT CLEARING 26 0.0069
241 LIVER DISORDER 307 0.0069
242 SLEEP DISORDER 488 0.0069
243 PROTEIN TOTAL DECREASED 26 0.0069
244 SWELLING 644 0.0069
245 MOBILITY DECREASED 492 0.0068
246 BLOOD POTASSIUM INCREASED 111 0.0068
247 ARTERIOSCLEROSIS 64 0.0068
248 CARDIAC MURMUR 58 0.0067
249 NORMAL NEWBORN 36 0.0066
250 DISCOMFORT 404 0.0066
251 CYST 82 0.0066
252 VARICOSE VEIN 34 0.0066
253 CATARACT OPERATION 39 0.0066
254 VENTRICULAR EXTRASYSTOLES 68 0.0065
255 GENERAL SYMPTOM 49 0.0065
256 BREATH SOUNDS ABNORMAL 32 0.0065
257 LUNG DISORDER 318 0.0065
258 GASTROINTESTINAL DISORDER 577 0.0064
259 INCREASED UPPER AIRWAY SECRETION 33 0.0064
260 MUSCULOSKELETAL STIFFNESS 562 0.0064
261 CEREBRAL ISCHAEMIA 33 0.0064
262 LIVER FUNCTION TEST INCREASED 137 0.0064
263 ASCITES 187 0.0064
264 SNORING 24 0.0063
265 CONTUSION 611 0.0063
266 C-REACTIVE PROTEIN INCREASED 230 0.0063
267 UPPER RESPIRATORY TRACT INFECTION 291 0.0063
268 ILL-DEFINED DISORDER 382 0.0063
269 FOOT OPERATION 31 0.0063
270 TASTE DISORDER 127 0.0063
271 OEDEMA PERIPHERAL 763 0.0063
272 ADVERSE REACTION 83 0.0063
273 CHOLELITHIASIS 205 0.0062
274 INTERNATIONAL NORMALISED RATIO DECREASED 25 0.0062
275 WRIST FRACTURE 74 0.0062
276 DRUG INTOLERANCE 594 0.0061
277 HIATUS HERNIA 79 0.0061
278 CARDIOMEGALY 75 0.0061
279 INFLAMMATORY MARKER INCREASED 30 0.0060
280 RENAL FUNCTION TEST ABNORMAL 28 0.0060
281 RED CELL DISTRIBUTION WIDTH INCREASED 25 0.0060
282 STOMACH DISCOMFORT 31 0.0060
283 CHOLECYSTITIS 71 0.0060
284 INFLAMMATION 306 0.0059
285 PRESCRIBED UNDERDOSE 118 0.0059
286 MULTIPLE ORGAN DYSFUNCTION SYNDROME 167 0.0059
287 DECUBITUS ULCER 48 0.0059
288 CARDIOMYOPATHY 87 0.0059
289 TRIGGER FINGER 24 0.0059
290 GOITRE 24 0.0059
291 TIBIA FRACTURE 27 0.0058
292 ASTHMA 649 0.0057
293 DYSPEPSIA 558 0.0057
294 RED BLOOD CELL COUNT DECREASED 162 0.0057
295 GENERAL PHYSICAL HEALTH DETERIORATION 653 0.0056
296 BACTERIAL INFECTION 105 0.0056
297 NEPHROGENIC ANAEMIA 26 0.0056
298 ANOREXIA 72 0.0056
299 FREQUENT BOWEL MOVEMENTS 150 0.0055
300 TREATMENT FAILURE 458 0.0055
301 JOINT EFFUSION 38 0.0055
302 CHOLECYSTITIS ACUTE 31 0.0055
303 CORONARY ARTERY DISEASE 165 0.0054
304 HYPOTHYROIDISM 173 0.0054
305 WHEELCHAIR USER 24 0.0054
306 ORTHOSTATIC HYPOTENSION 94 0.0054
307 FAILURE TO THRIVE 28 0.0054
308 HUMERUS FRACTURE 26 0.0054
309 PROTHROMBIN TIME PROLONGED 32 0.0053
310 CHOLECYSTECTOMY 61 0.0053
311 HYPOXIA 188 0.0053
312 BLADDER DISORDER 53 0.0053
313 EAR INFECTION 142 0.0053
314 ACUTE RESPIRATORY FAILURE 102 0.0053
315 JOINT STIFFNESS 139 0.0053
316 PREGNANCY 106 0.0053
317 BACK DISORDER 86 0.0053
318 ARTERIOSCLEROSIS CORONARY ARTERY 35 0.0053
319 PHARYNGOLARYNGEAL PAIN 28 0.0053
320 NEURALGIA 127 0.0052
321 REFUSAL OF TREATMENT BY PATIENT 34 0.0052
322 MUSCLE STRAIN 45 0.0052
323 SPINAL COMPRESSION FRACTURE 43 0.0052
324 EXPOSURE DURING PREGNANCY 323 0.0052
325 HYPONATRAEMIA 291 0.0052
326 ASPIRATION 56 0.0051
327 DRUG-INDUCED LIVER INJURY 160 0.0051
328 ULCER 81 0.0051
329 GLUCOSE TOLERANCE IMPAIRED 30 0.0051
330 ROTATOR CUFF SYNDROME 65 0.0051
331 FLUID RETENTION 257 0.0050
332 ABDOMINAL TENDERNESS 25 0.0050
333 HYPERTENSION 1066 0.0050
334 ATRIAL FLUTTER 40 0.0050
335 RALES 29 0.0050
336 PERIPHERAL SWELLING 765 0.0050
337 URTICARIA 827 0.0049
338 GOUT 88 0.0049
339 RECTAL HAEMORRHAGE 210 0.0049
340 INTERNATIONAL NORMALISED RATIO INCREASED 139 0.0049
341 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 254 0.0049
342 CONFUSIONAL STATE 782 0.0048
343 TENDERNESS 50 0.0048
344 ORAL CANDIDIASIS 63 0.0048
345 BLOOD UREA INCREASED 80 0.0048
346 MACULAR DEGENERATION 57 0.0048
347 LYMPHOEDEMA 33 0.0048
348 ABDOMINAL PAIN UPPER 979 0.0048
349 FLUSHING 483 0.0047
350 RENAL FAILURE ACUTE 201 0.0047
351 EPILEPSY 144 0.0047
352 VISUAL DISTURBANCE 27 0.0047
353 FLANK PAIN 44 0.0047
354 COMA 223 0.0047
355 DEEP VEIN THROMBOSIS 303 0.0047
356 UTERINE LEIOMYOMA 34 0.0046
357 LEUKOCYTOSIS 84 0.0046
358 MICTURITION URGENCY 53 0.0046
359 MATERNAL EXPOSURE DURING PREGNANCY 413 0.0046
360 CHEST PAIN 856 0.0046
361 ANGINA UNSTABLE 30 0.0046
362 HAEMORRHOIDS 90 0.0046
363 MALNUTRITION 51 0.0046
364 HYPERSENSITIVITY 846 0.0046
365 END STAGE RENAL DISEASE 83 0.0045
366 ABNORMAL LOSS OF WEIGHT 31 0.0045
367 INFECTION 656 0.0045
368 PULMONARY EMBOLISM 430 0.0045
369 THERAPY NON-RESPONDER 203 0.0045
370 ABDOMINAL DISCOMFORT 755 0.0045
371 COVID-19 PNEUMONIA 53 0.0045
372 CELLULITIS 226 0.0045
373 COMPRESSION FRACTURE 24 0.0045
374 ASPARTATE AMINOTRANSFERASE INCREASED 237 0.0045
375 GINGIVITIS 24 0.0044
376 SKIN LESION 121 0.0044
377 OBSTRUCTIVE AIRWAYS DISORDER 49 0.0044
378 MENISCUS INJURY 27 0.0044
379 RENAL TUBULAR NECROSIS 43 0.0044
380 PRODUCT ADMINISTRATION INTERRUPTED 34 0.0043
381 GASTRIC ULCER HAEMORRHAGE 24 0.0043
382 ABDOMINAL DISTENSION 450 0.0043
383 FEELING HOT 264 0.0043
384 WEIGHT FLUCTUATION 45 0.0043
385 POLYP 28 0.0043
386 NECK PAIN 239 0.0043
387 RASH ERYTHEMATOUS 204 0.0043
388 INTENTIONAL PRODUCT USE ISSUE 373 0.0043
389 LACERATION 40 0.0042
390 OBSESSIVE-COMPULSIVE DISORDER 34 0.0042
391 UROSEPSIS 39 0.0042
392 ECONOMIC PROBLEM 64 0.0042
393 SINUS DISORDER 83 0.0042
394 TOOTH EXTRACTION 52 0.0042
395 NEPHROPATHY 39 0.0042
396 DYSPNOEA EXERTIONAL 157 0.0042
397 HAEMOGLOBIN DECREASED 427 0.0042
398 URINARY INCONTINENCE 123 0.0041
399 HOSPICE CARE 41 0.0041
400 HYPOAESTHESIA 615 0.0041
401 URINE ODOUR ABNORMAL 24 0.0041
402 RESPIRATORY DEPRESSION 50 0.0041
403 DECREASED IMMUNE RESPONSIVENESS 40 0.0041
404 DENTAL CARIES 45 0.0041
405 DEFORMITY 38 0.0041
406 TRANSIENT ISCHAEMIC ATTACK 137 0.0041
407 BLOOD SODIUM DECREASED 76 0.0040
408 OESOPHAGITIS 44 0.0040
409 CONSTIPATION 878 0.0040
410 INCREASED TENDENCY TO BRUISE 37 0.0040
411 FOOT FRACTURE 76 0.0040
412 BACK PAIN 926 0.0040
413 SQUAMOUS CELL CARCINOMA OF SKIN 24 0.0040
414 WHITE BLOOD CELL COUNT INCREASED 152 0.0040
415 ASTHENIA 1489 0.0040
416 ANAEMIA 755 0.0040
417 VAGINAL DISCHARGE 40 0.0039
418 AMNESIA 257 0.0039
419 RIB FRACTURE 81 0.0039
420 PLEURAL EFFUSION 239 0.0039
421 SEPSIS 438 0.0039
422 UPPER GASTROINTESTINAL HAEMORRHAGE 66 0.0039
423 LOWER GASTROINTESTINAL HAEMORRHAGE 29 0.0039
424 SECRETION DISCHARGE 49 0.0039
425 GASTROINTESTINAL PAIN 43 0.0039
426 ARTHRITIS 306 0.0039
427 MENTAL STATUS CHANGES 108 0.0039
428 JOINT INJURY 83 0.0039
429 INSOMNIA 1034 0.0039
430 ATRIAL FIBRILLATION 378 0.0039
431 HYPOKALAEMIA 179 0.0039
432 LOW DENSITY LIPOPROTEIN INCREASED 30 0.0039
433 ANGINA PECTORIS 111 0.0039
434 HYDRONEPHROSIS 29 0.0039
435 PHARYNGITIS 48 0.0039
436 BRONCHIECTASIS 26 0.0039
437 MUSCULAR WEAKNESS 437 0.0038
438 ABASIA 95 0.0038
439 MAJOR DEPRESSION 28 0.0038
440 SMALL INTESTINAL OBSTRUCTION 47 0.0038
441 MELAENA 84 0.0038
442 PARAESTHESIA ORAL 55 0.0038
443 TOOTH FRACTURE 42 0.0038
444 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 183 0.0038
445 SPINAL DISORDER 36 0.0038
446 GASTRITIS 100 0.0038
447 BLOOD PRESSURE DIASTOLIC DECREASED 28 0.0038
448 BLOOD IRON DECREASED 45 0.0038
449 NOCTURIA 46 0.0038
450 BLOOD CREATININE INCREASED 247 0.0038
451 MYOCARDIAL ISCHAEMIA 43 0.0038
452 ONYCHOCLASIS 26 0.0038
453 OROPHARYNGEAL DISCOMFORT 34 0.0038
454 ANKLE FRACTURE 58 0.0037
455 PETECHIAE 39 0.0037
456 LUNG INFILTRATION 33 0.0037
457 WEIGHT INCREASED 836 0.0037
458 MUSCLE SPASMS 685 0.0037
459 PROCTALGIA 24 0.0037
460 MALIGNANT MELANOMA 50 0.0037
461 TOOTH ABSCESS 38 0.0037
462 HYPERCALCAEMIA 46 0.0037
463 POOR QUALITY SLEEP 80 0.0037
464 MYOPATHY 32 0.0037
465 ELECTROCARDIOGRAM ABNORMAL 29 0.0037
466 MIGRAINE 352 0.0037
467 MOUTH HAEMORRHAGE 27 0.0037
468 ALOPECIA 723 0.0037
469 TENDONITIS 57 0.0037
470 NASOPHARYNGITIS 678 0.0037
471 CLOSTRIDIUM DIFFICILE COLITIS 39 0.0037
472 PERICARDIAL EFFUSION 85 0.0037
473 HEPATITIS 94 0.0037
474 EATING DISORDER 78 0.0037
475 HYPOTHERMIA 37 0.0037
476 INJECTION SITE HAEMATOMA 53 0.0036
477 HEPATIC STEATOSIS 68 0.0036
478 CORONARY ARTERY OCCLUSION 50 0.0036
479 ABDOMINAL PAIN 846 0.0036
480 SEPTIC SHOCK 158 0.0036
481 HYPOALBUMINAEMIA 28 0.0036
482 NERVE INJURY 40 0.0036
483 LEFT VENTRICULAR DYSFUNCTION 24 0.0036
484 CYSTITIS 114 0.0036
485 INTERVERTEBRAL DISC PROTRUSION 78 0.0036
486 RIGHT VENTRICULAR FAILURE 25 0.0036
487 BLOOD POTASSIUM DECREASED 107 0.0036
488 BRONCHITIS 262 0.0035
489 GROIN PAIN 31 0.0035
490 PLATELET COUNT INCREASED 46 0.0035
491 MUSCULOSKELETAL DISORDER 67 0.0035
492 ALANINE AMINOTRANSFERASE INCREASED 216 0.0035
493 URINARY TRACT INFECTION 600 0.0035
494 PAIN IN EXTREMITY 1026 0.0035
495 PARAESTHESIA 547 0.0035
496 MULTIPLE FRACTURES 57 0.0035
497 RESPIRATORY FAILURE 253 0.0035
498 PELVIC FRACTURE 27 0.0035
499 PULMONARY HYPERTENSION 72 0.0035
500 PAIN 2123 0.0035
501 HYPOMAGNESAEMIA 48 0.0034
502 SUPRAVENTRICULAR TACHYCARDIA 33 0.0034
503 LIVER FUNCTION TEST ABNORMAL 100 0.0034
504 FLUID OVERLOAD 50 0.0034
505 BLOOD URINE PRESENT 65 0.0034
506 DEPRESSION 778 0.0034
507 AORTIC ANEURYSM 26 0.0034
508 ENCEPHALOPATHY 83 0.0034
509 RETCHING 72 0.0034
510 BACTERAEMIA 40 0.0034
511 VOMITING 1584 0.0034
512 PYREXIA 1163 0.0034
513 ACUTE MYOCARDIAL INFARCTION 99 0.0034
514 SENSORY LOSS 27 0.0034
515 DEVICE FAILURE 51 0.0033
516 BLOOD TRIGLYCERIDES INCREASED 59 0.0033
517 HAEMODIALYSIS 28 0.0033
518 SPLENOMEGALY 39 0.0033
519 GASTRIC ULCER 63 0.0033
520 OSTEOMYELITIS 60 0.0033
521 BLOOD ALKALINE PHOSPHATASE INCREASED 82 0.0033
522 MASS 46 0.0033
523 PERIPHERAL COLDNESS 45 0.0033
524 RASH 1426 0.0033
525 GINGIVAL PAIN 26 0.0033
526 CATARACT 194 0.0033
527 NERVE COMPRESSION 30 0.0032
528 TRANSFUSION 34 0.0032
529 BLOOD MAGNESIUM DECREASED 28 0.0032
530 LIGAMENT SPRAIN 32 0.0032
531 LYMPHOCYTE COUNT DECREASED 57 0.0032
532 LABORATORY TEST ABNORMAL 95 0.0032
533 SKIN LACERATION 35 0.0032
534 URINE OUTPUT DECREASED 28 0.0032
535 TOOTH DISORDER 71 0.0032
536 SOMNOLENCE 642 0.0032
537 HAEMATURIA 109 0.0032
538 DECREASED APPETITE 737 0.0032
539 EMPHYSEMA 32 0.0032
540 PURPURA 28 0.0032
541 CARDIAC FAILURE CONGESTIVE 254 0.0032
542 CONDITION AGGRAVATED 960 0.0032
543 COORDINATION ABNORMAL 44 0.0032
544 HYPERHIDROSIS 406 0.0031
545 ARTHRALGIA 1304 0.0031
546 RESTLESS LEGS SYNDROME 57 0.0031
547 SKIN ULCER 81 0.0031
548 PNEUMONIA 1014 0.0031
549 EMBOLISM 26 0.0031
550 BONE DISORDER 57 0.0031
551 ANHEDONIA 82 0.0031
552 RENAL PAIN 33 0.0031
553 BALANCE DISORDER 269 0.0031
554 SINUS CONGESTION 42 0.0031
555 HAEMOLYSIS 24 0.0031
556 FLATULENCE 176 0.0031
557 POST PROCEDURAL HAEMORRHAGE 36 0.0031
558 HYPOPHAGIA 79 0.0031
559 PNEUMOTHORAX 49 0.0031
560 RESPIRATORY TRACT CONGESTION 49 0.0031
561 MUSCULOSKELETAL DISCOMFORT 53 0.0031
562 GAIT DISTURBANCE 589 0.0031
563 DRY EYE 153 0.0031
564 NODULE 40 0.0031
565 STAPHYLOCOCCAL INFECTION 101 0.0031
566 BRADYCARDIA 162 0.0031
567 HEART RATE IRREGULAR 69 0.0031
568 HEPATOMEGALY 30 0.0030
569 NEPHROLITHIASIS 140 0.0030
570 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 217 0.0030
571 ERUCTATION 59 0.0030
572 HAEMATOMA 79 0.0030
573 ANXIETY 867 0.0030
574 DYSURIA 112 0.0030
575 VITAMIN D DECREASED 26 0.0030
576 FATIGUE 2366 0.0030
577 PRURITUS 1166 0.0030
578 SKIN INFECTION 34 0.0030
579 DYSPNOEA 1715 0.0030
580 FALL 1006 0.0030
581 GASTROENTERITIS 44 0.0030
582 MEMORY IMPAIRMENT 413 0.0030
583 FAECES DISCOLOURED 65 0.0030
584 BODY HEIGHT DECREASED 32 0.0030
585 DIZZINESS POSTURAL 29 0.0030
586 MUSCULOSKELETAL CHEST PAIN 46 0.0030
587 DEHYDRATION 396 0.0030
588 VENTRICULAR TACHYCARDIA 49 0.0030
589 THROMBOSIS 238 0.0030
590 PULMONARY MASS 44 0.0030
591 BASAL CELL CARCINOMA 46 0.0029
592 HAEMOPTYSIS 82 0.0029
593 GASTROINTESTINAL HAEMORRHAGE 245 0.0029
594 ACTIVITIES OF DAILY LIVING IMPAIRED 58 0.0029
595 PULMONARY OEDEMA 131 0.0029
596 GRAND MAL CONVULSION 27 0.0029
597 THROMBOCYTOPENIA 327 0.0029
598 HEADACHE 1833 0.0029
599 HOT FLUSH 220 0.0029
600 FACIAL PAIN 26 0.0029
601 PULMONARY CONGESTION 38 0.0029
602 DIARRHOEA 1859 0.0029
603 LIMB INJURY 78 0.0029
604 PRURITUS GENERALISED 62 0.0029
605 ADVERSE DRUG REACTION 257 0.0029
606 POLLAKIURIA 119 0.0029
607 SPUTUM DISCOLOURED 27 0.0028
608 MUSCLE TIGHTNESS 46 0.0028
609 INCONTINENCE 30 0.0028
610 WEIGHT DECREASED 792 0.0028
611 HEMIPARESIS 48 0.0028
612 NEUTROPHIL COUNT INCREASED 29 0.0028
613 CONVULSION 161 0.0028
614 BRAIN INJURY 28 0.0028
615 HEPATIC ENCEPHALOPATHY 26 0.0028
616 PSYCHOLOGICAL TRAUMA 24 0.0028
617 MULTI-ORGAN FAILURE 48 0.0028
618 HYPERGLYCAEMIA 101 0.0028
619 GENERALISED OEDEMA 34 0.0027
620 HYPOTENSION 551 0.0027
621 SINUS TACHYCARDIA 39 0.0027
622 TRANSAMINASES INCREASED 61 0.0027
623 ILEUS 34 0.0027
624 DIZZINESS 1362 0.0027
625 AGEUSIA 68 0.0027
626 COGNITIVE DISORDER 127 0.0027
627 DERMATITIS CONTACT 31 0.0027
628 GINGIVAL BLEEDING 37 0.0027
629 CHILLS 317 0.0027
630 TACHYCARDIA 240 0.0027
631 COAGULOPATHY 45 0.0027
632 TOXIC EPIDERMAL NECROLYSIS 41 0.0027
633 ABSCESS 43 0.0027
634 SINUS BRADYCARDIA 26 0.0027
635 THIRST 48 0.0027
636 PRODUCTIVE COUGH 128 0.0027
637 PRESYNCOPE 65 0.0027
638 INJECTION SITE IRRITATION 34 0.0027
639 SYNCOPE 267 0.0027
640 BLOOD PRESSURE SYSTOLIC INCREASED 52 0.0027
641 FEELING COLD 74 0.0027
642 INTENTIONAL PRODUCT MISUSE 232 0.0026
643 IMPAIRED QUALITY OF LIFE 38 0.0026
644 RENAL DISORDER 123 0.0026
645 INITIAL INSOMNIA 27 0.0026
646 PANCREATITIS 139 0.0026
647 SCAR 45 0.0026
648 HEART RATE DECREASED 92 0.0026
649 DIPLOPIA 68 0.0026
650 COLITIS 99 0.0026
651 RESPIRATORY TRACT INFECTION 68 0.0026
652 DIABETES MELLITUS 199 0.0026
653 UPPER LIMB FRACTURE 52 0.0026
654 FEAR 70 0.0026
655 OVARIAN CYST 26 0.0026
656 AFFECT LABILITY 25 0.0026
657 PROCEDURAL PAIN 72 0.0026
658 BURNING SENSATION 182 0.0026
659 COLITIS ULCERATIVE 116 0.0026
660 THYROID DISORDER 40 0.0026
661 PREMATURE DELIVERY 41 0.0026
662 HYPERKALAEMIA 90 0.0026
663 ORAL HERPES 50 0.0026
664 NAUSEA 2027 0.0026
665 SKIN DISORDER 85 0.0025
666 GLAUCOMA 49 0.0025
667 INCORRECT PRODUCT ADMINISTRATION DURATION 55 0.0025
668 DIALYSIS 36 0.0025
669 DIVERTICULITIS 70 0.0025
670 CLOSTRIDIUM DIFFICILE INFECTION 55 0.0025
671 PALPITATIONS 295 0.0025
672 NASAL CONGESTION 148 0.0025
673 TINNITUS 115 0.0025
674 EPISTAXIS 187 0.0025
675 ADVERSE EVENT 229 0.0025
676 LOCALISED INFECTION 60 0.0025
677 MENTAL IMPAIRMENT 60 0.0025
678 PNEUMONITIS 67 0.0025
679 BRAIN OEDEMA 31 0.0025
680 SEDATION 64 0.0024
681 BREAST PAIN 26 0.0024
682 MYALGIA 414 0.0024
683 PRODUCT USE ISSUE 457 0.0024
684 HERNIA 47 0.0024
685 MEDICATION ERROR 135 0.0024
686 HAEMATOCHEZIA 134 0.0024
687 TOOTH INFECTION 32 0.0024
688 HYPERTHYROIDISM 35 0.0024
689 BLOOD PRESSURE DECREASED 160 0.0024
690 ARRHYTHMIA 114 0.0024
691 HYPERSOMNIA 69 0.0024
692 DEVICE RELATED INFECTION 37 0.0024
693 SEASONAL ALLERGY 34 0.0024
694 PLATELET COUNT DECREASED 256 0.0024
695 RHINORRHOEA 155 0.0024
696 POST PROCEDURAL COMPLICATION 46 0.0024
697 ERYTHEMA 490 0.0024
698 CONJUNCTIVITIS 44 0.0024
699 DEAFNESS 62 0.0024
700 BLOOD BILIRUBIN INCREASED 64 0.0024
701 HIP FRACTURE 76 0.0024
702 BLOOD CREATINE PHOSPHOKINASE INCREASED 68 0.0024
703 EYE PAIN 133 0.0024
704 MIDDLE INSOMNIA 44 0.0024
705 CHROMATURIA 53 0.0023
706 IMPAIRED GASTRIC EMPTYING 32 0.0023
707 SPINAL FRACTURE 47 0.0023
708 DISSEMINATED INTRAVASCULAR COAGULATION 33 0.0023
709 FUNGAL INFECTION 78 0.0023
710 LETHARGY 134 0.0023
711 DYSPHONIA 136 0.0023
712 ELECTROLYTE IMBALANCE 27 0.0023
713 NEUROPATHY PERIPHERAL 221 0.0023
714 EYE HAEMORRHAGE 31 0.0023
715 VASCULITIS 27 0.0023
716 LUNG INFECTION 36 0.0023
717 EJECTION FRACTION DECREASED 36 0.0023
718 PHARMACEUTICAL PRODUCT COMPLAINT 60 0.0023
719 ADRENAL INSUFFICIENCY 28 0.0023
720 COUGH 645 0.0023
721 PAIN IN JAW 65 0.0023
722 IMPAIRED WORK ABILITY 49 0.0023
723 MYELODYSPLASTIC SYNDROME 33 0.0023
724 GLOMERULAR FILTRATION RATE DECREASED 28 0.0023
725 BONE DENSITY DECREASED 71 0.0023
726 CHEST DISCOMFORT 232 0.0023
727 DELUSION 35 0.0023
728 DYSPHAGIA 213 0.0022
729 HEAD INJURY 71 0.0022
730 BREAST CANCER METASTATIC 24 0.0022
731 LYMPHADENOPATHY 79 0.0022
732 LIMB DISCOMFORT 69 0.0022
733 BONE PAIN 130 0.0022
734 HYPOCALCAEMIA 42 0.0022
735 ABDOMINAL PAIN LOWER 56 0.0022
736 NO THERAPEUTIC RESPONSE 27 0.0022
737 WHITE BLOOD CELL COUNT DECREASED 240 0.0022
738 EYE INFECTION 25 0.0022
739 OXYGEN SATURATION DECREASED 124 0.0022
740 HYPOAESTHESIA ORAL 33 0.0022
741 SNEEZING 49 0.0022
742 MOUTH ULCERATION 46 0.0022
743 PHOTOSENSITIVITY REACTION 36 0.0022
744 INFUSION SITE PAIN 28 0.0022
745 UNRESPONSIVE TO STIMULI 56 0.0022
746 DISTURBANCE IN ATTENTION 117 0.0022
747 VIRAL INFECTION 72 0.0022
748 BLOOD PRESSURE INCREASED 330 0.0022
749 COLD SWEAT 38 0.0022
750 SKIN DISCOLOURATION 99 0.0022
751 BEDRIDDEN 28 0.0021
752 HAEMATEMESIS 54 0.0021
753 PANCYTOPENIA 119 0.0021
754 RASH PRURITIC 115 0.0021
755 RENAL FAILURE 280 0.0021
756 CHOKING 41 0.0021
757 TOOTHACHE 38 0.0021
758 DYSARTHRIA 79 0.0021
759 DEPRESSED LEVEL OF CONSCIOUSNESS 83 0.0021
760 TREMOR 347 0.0021
761 VISION BLURRED 287 0.0021
762 HERPES ZOSTER 120 0.0021
763 RASH MACULAR 73 0.0021
764 HUNGER 29 0.0021
765 MANIA 34 0.0021
766 MALAISE 906 0.0021
767 RESPIRATORY DISTRESS 57 0.0021
768 MUSCLE ATROPHY 26 0.0021
769 THERAPEUTIC RESPONSE UNEXPECTED 92 0.0020
770 FEELING JITTERY 39 0.0020
771 JAUNDICE 55 0.0020
772 ACUTE RESPIRATORY DISTRESS SYNDROME 36 0.0020
773 FULL BLOOD COUNT DECREASED 41 0.0020
774 CARDIO-RESPIRATORY ARREST 85 0.0020
775 DRUG ERUPTION 36 0.0020
776 ATAXIA 24 0.0020
777 HYPOGLYCAEMIA 98 0.0020
778 HEART RATE INCREASED 200 0.0020
779 ISCHAEMIC STROKE 36 0.0020
780 ACUTE KIDNEY INJURY 308 0.0020
781 BLOOD PRESSURE ABNORMAL 40 0.0020
782 CARDIOVASCULAR DISORDER 51 0.0020
783 RASH GENERALISED 52 0.0020
784 DYSGEUSIA 149 0.0020
785 DERMATITIS 42 0.0020
786 SPEECH DISORDER 105 0.0020
787 DEMENTIA 56 0.0020
788 HALLUCINATION 151 0.0020
789 GASTROENTERITIS VIRAL 36 0.0020
790 SENSORY DISTURBANCE 32 0.0020
791 TREATMENT NONCOMPLIANCE 109 0.0020
792 LACRIMATION INCREASED 60 0.0020
793 OROPHARYNGEAL PAIN 183 0.0020
794 MENTAL DISORDER 86 0.0020
795 PRODUCT PRESCRIBING ERROR 47 0.0020
796 NERVOUSNESS 103 0.0020
797 ORAL PAIN 44 0.0020
798 THROAT TIGHTNESS 53 0.0020
799 WRONG TECHNIQUE IN DRUG USAGE PROCESS 71 0.0020
800 FEBRILE NEUTROPENIA 129 0.0019
801 RESTLESSNESS 71 0.0019
802 LEUKOPENIA 97 0.0019
803 NEUTROPHIL COUNT DECREASED 79 0.0019
804 PRODUCT USE IN UNAPPROVED INDICATION 480 0.0019
805 KIDNEY INFECTION 38 0.0019
806 APHONIA 27 0.0019
807 CARDIAC ARREST 159 0.0019
808 FEEDING DISORDER 39 0.0019
809 URINARY RETENTION 64 0.0019
810 DYSSTASIA 56 0.0019
811 BLOOD GLUCOSE INCREASED 361 0.0019
812 THERAPEUTIC RESPONSE DECREASED 116 0.0019
813 BLOOD COUNT ABNORMAL 29 0.0019
814 SURGERY 112 0.0019
815 SKIN CANCER 41 0.0019
816 VERTIGO 116 0.0019
817 FRACTURE 36 0.0019
818 CEREBROVASCULAR ACCIDENT 321 0.0019
819 PANIC ATTACK 69 0.0019
820 RENAL IMPAIRMENT 159 0.0019
821 CARDIAC DISORDER 177 0.0019
822 VISUAL IMPAIRMENT 232 0.0019
823 THROAT IRRITATION 84 0.0019
824 PSORIASIS 240 0.0018
825 BLOOD GLUCOSE DECREASED 88 0.0018
826 OFF LABEL USE 1601 0.0018
827 FEELING ABNORMAL 438 0.0018
828 SWOLLEN TONGUE 57 0.0018
829 DRUG INTERACTION 287 0.0018
830 PHOTOPHOBIA 34 0.0018
831 ERECTILE DYSFUNCTION 46 0.0018
832 HYPOKINESIA 26 0.0018
833 UNDERDOSE 130 0.0018
834 MYOCARDIAL INFARCTION 310 0.0018
835 INFLUENZA LIKE ILLNESS 146 0.0018
836 INFLUENZA 197 0.0018
837 TACHYPNOEA 24 0.0018
838 LOSS OF CONSCIOUSNESS 225 0.0018
839 SWELLING FACE 114 0.0017
840 SUBDURAL HAEMATOMA 25 0.0017
841 ABNORMAL DREAMS 48 0.0017
842 EYE DISORDER 57 0.0017
843 APHASIA 52 0.0017
844 EMOTIONAL DISORDER 53 0.0017
845 VISUAL ACUITY REDUCED 57 0.0017
846 HEPATOTOXICITY 38 0.0017
847 RASH PAPULAR 38 0.0017
848 HEAD DISCOMFORT 30 0.0017
849 MUSCLE TWITCHING 39 0.0017
850 PALLOR 46 0.0017
851 PHARYNGEAL OEDEMA 26 0.0017
852 PARALYSIS 24 0.0017
853 DYSKINESIA 68 0.0017
854 DISORIENTATION 66 0.0017
855 STEVENS-JOHNSON SYNDROME 37 0.0017
856 THINKING ABNORMAL 31 0.0017
857 LOCAL SWELLING 29 0.0017
858 INTESTINAL OBSTRUCTION 62 0.0016
859 EMOTIONAL DISTRESS 199 0.0016
860 BLOOD LACTATE DEHYDROGENASE INCREASED 26 0.0016
861 RHABDOMYOLYSIS 68 0.0016
862 BLOOD PRESSURE FLUCTUATION 39 0.0016
863 GAMMA-GLUTAMYLTRANSFERASE INCREASED 36 0.0016
864 INCREASED APPETITE 31 0.0016
865 CEREBRAL HAEMORRHAGE 58 0.0016
866 LYMPHOMA 25 0.0016
867 DRUG ADMINISTRATION ERROR 49 0.0016
868 CHRONIC KIDNEY DISEASE 121 0.0016
869 HAEMORRHAGE 166 0.0016
870 DRUG EFFECT DECREASED 85 0.0016
871 PSYCHOMOTOR HYPERACTIVITY 26 0.0016
872 MUCOSAL INFLAMMATION 41 0.0016
873 PANCREATITIS ACUTE 35 0.0016
874 CANDIDA INFECTION 26 0.0015
875 APPLICATION SITE ERYTHEMA 40 0.0015
876 PARANOIA 26 0.0015
877 OSTEONECROSIS OF JAW 37 0.0015
878 PRODUCT QUALITY ISSUE 203 0.0015
879 PELVIC PAIN 27 0.0015
880 GASTRIC DISORDER 51 0.0015
881 SHOCK 34 0.0015
882 ELECTROCARDIOGRAM QT PROLONGED 53 0.0015
883 PROTEINURIA 28 0.0015
884 APPLICATION SITE PRURITUS 33 0.0015
885 DISEASE PROGRESSION 172 0.0015
886 AGITATION 106 0.0014
887 HYPOACUSIS 62 0.0014
888 OCULAR HYPERAEMIA 68 0.0014
889 CARDIAC FAILURE 115 0.0014
890 EYE SWELLING 53 0.0014
891 ABNORMAL BEHAVIOUR 56 0.0014
892 DIABETES MELLITUS INADEQUATE CONTROL 25 0.0014
893 DRUG EXPOSURE DURING PREGNANCY 48 0.0014
894 CRYING 51 0.0014
895 MOVEMENT DISORDER 45 0.0014
896 MULTIPLE SCLEROSIS 67 0.0014
897 INJECTION SITE REACTION 96 0.0014
898 TUBULOINTERSTITIAL NEPHRITIS 26 0.0014
899 LIP SWELLING 46 0.0014
900 COVID-19 242 0.0014
901 RESPIRATORY ARREST 38 0.0014
902 OSTEONECROSIS 45 0.0014
903 DRUG INEFFECTIVE 1800 0.0014
904 ANGER 46 0.0014
905 ECZEMA 71 0.0014
906 HOSPITALISATION 206 0.0013
907 ANAPHYLACTIC REACTION 74 0.0013
908 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 31 0.0013
909 HEPATIC FAILURE 40 0.0013
910 HEPATIC FUNCTION ABNORMAL 49 0.0013
911 RASH MACULO-PAPULAR 29 0.0013
912 SEROTONIN SYNDROME 25 0.0013
913 IRRITABILITY 78 0.0013
914 EYE IRRITATION 74 0.0013
915 BLINDNESS 52 0.0013
916 TOOTH LOSS 26 0.0013
917 DEPRESSED MOOD 66 0.0012
918 OVERDOSE 269 0.0012
919 ALTERED STATE OF CONSCIOUSNESS 27 0.0012
920 CYTOKINE RELEASE SYNDROME 25 0.0012
921 INCORRECT DRUG ADMINISTRATION DURATION 35 0.0012
922 NEOPLASM PROGRESSION 43 0.0012
923 SUICIDAL IDEATION 113 0.0012
924 GLYCOSYLATED HAEMOGLOBIN INCREASED 31 0.0012
925 NEUTROPENIA 167 0.0012
926 MOOD SWINGS 39 0.0012
927 DRY SKIN 162 0.0012
928 LACTIC ACIDOSIS 39 0.0012
929 INTENTIONAL DRUG MISUSE 25 0.0012
930 CEREBRAL INFARCTION 29 0.0012
931 VAGINAL HAEMORRHAGE 51 0.0012
932 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 83 0.0012
933 ABORTION SPONTANEOUS 46 0.0011
934 ANGIOEDEMA 50 0.0011
935 DRUG RESISTANCE 29 0.0011
936 UNEVALUABLE EVENT 85 0.0011
937 INJECTION SITE PRURITUS 74 0.0011
938 THERAPY INTERRUPTED 78 0.0011
939 MALIGNANT NEOPLASM PROGRESSION 110 0.0011
940 PREMATURE BABY 32 0.0011
941 INJECTION SITE URTICARIA 26 0.0011
942 PRODUCT DOSE OMISSION IN ERROR 30 0.0011
943 AGGRESSION 53 0.0011
944 SKIN EXFOLIATION 89 0.0011
945 MOOD ALTERED 28 0.0010
946 NERVOUS SYSTEM DISORDER 32 0.0010
947 PSYCHOTIC DISORDER 30 0.0010
948 SEIZURE 117 0.0010
949 MULTIPLE SCLEROSIS RELAPSE 69 0.0010
950 DIABETIC KETOACIDOSIS 24 0.0010
951 ILLNESS 102 0.0010
952 BREAST CANCER 91 0.0010
953 WITHDRAWAL SYNDROME 40 0.0010
954 EYE PRURITUS 32 0.0010
955 METABOLIC ACIDOSIS 29 0.0009
956 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 163 0.0009
957 PANCREATIC CARCINOMA 26 0.0009
958 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 49 0.0009
959 INJECTION SITE ERYTHEMA 109 0.0009
960 SKIN IRRITATION 40 0.0009
961 NIGHTMARE 30 0.0009
962 PRODUCT DOSE OMISSION ISSUE 252 0.0009
963 INCORRECT DOSE ADMINISTERED 195 0.0009
964 LUNG NEOPLASM MALIGNANT 35 0.0009
965 DRUG ABUSE 70 0.0008
966 DISEASE RECURRENCE 40 0.0008
967 PRODUCT ADHESION ISSUE 30 0.0008
968 INTERSTITIAL LUNG DISEASE 40 0.0008
969 NEOPLASM MALIGNANT 52 0.0008
970 ACCIDENTAL OVERDOSE 28 0.0008
971 TOXICITY TO VARIOUS AGENTS 126 0.0007
972 SKIN BURNING SENSATION 52 0.0007
973 DRUG DOSE OMISSION 119 0.0007
974 INJECTION SITE HAEMORRHAGE 57 0.0007
975 ACNE 54 0.0007
976 PLASMA CELL MYELOMA 27 0.0007
977 DEATH 589 0.0007
978 INJECTION SITE SWELLING 51 0.0007
979 DEVICE MALFUNCTION 46 0.0007
980 INJECTION SITE PAIN 198 0.0006
981 THERAPY CESSATION 33 0.0006
982 FOETAL EXPOSURE DURING PREGNANCY 52 0.0006
983 DRUG WITHDRAWAL SYNDROME 56 0.0006
984 DEVICE DISLOCATION 24 0.0006
985 NO ADVERSE EVENT 97 0.0005
986 PRODUCT DOSE OMISSION 33 0.0005
987 INJECTION SITE BRUISING 40 0.0005
988 SUICIDE ATTEMPT 29 0.0005
989 INTENTIONAL OVERDOSE 30 0.0005
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 87 0.0004
991 DRUG DEPENDENCE 65 0.0004
992 PROSTATE CANCER 32 0.0004
993 DEVICE ISSUE 24 0.0003